Microconversion between CYP21A2 and CYP21A1P Promoter Regions Causes the Nonclassical Form of 21-Hydroxylase Deficiency
Context: Most mutations causing 21-hydroxylase deficiency originate from microconversions between CYP21 pseudogenes and active genes. However, around 20% of the alleles in the nonclassical form (NC-21OHD) remain without identified mutations, suggesting the involvement of regulatory regions. The pseu...
Gespeichert in:
Veröffentlicht in: | The journal of clinical endocrinology and metabolism 2007-10, Vol.92 (10), p.4028-4034 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Context: Most mutations causing 21-hydroxylase deficiency originate from microconversions between CYP21 pseudogenes and active genes. However, around 20% of the alleles in the nonclassical form (NC-21OHD) remain without identified mutations, suggesting the involvement of regulatory regions. The pseudogene promoter is 80% less active than the CYP21A2 due to the presence of −126C>T, −113G>A, −110T>C, and −103A>G mutations. Additionally, mutations in the steroidogenic factor-1 binding sites of the CYP21 distal regulatory region, located at 4676 bases upstream from the cap site of the CYP21A2 gene, decrease its transcription to 35%.
Objective: The objective of the study was to investigate the CYP21A2 promoter/regulatory regions in NC-21OHD patients with undetermined genotype.
Subjects: The study included 17 NC-21OHD patients and 50 controls.
Methods: Promoter/regulatory regions were sequenced from peripheral leukocytes’ genomic DNA. The identified substitutions were evaluated through EMSA using −132/−97 wild-type and mutant probes and nuclear extracts from NCI-H295A cells. Transcriptional activity studies were performed with wild-type and mutant constructions transfected in NCI-H295A cells.
Results: No mutations were identified in the distal regulatory regions. The −126C>T, −113G>A, −110T>C promoter mutations were found in compound heterozygosity with the V281L mutation in one patient and the −126C>T mutation in compound heterozygosity with the I2 splice in another. The −126T mutation decreases the transcriptional activity to 52%, compatible with the patient’s nonclassical phenotype. EMSA demonstrated that the −132/−121 region is important for the DNA interaction with the specificity protein-1 transcription factor.
Conclusion: Microconversions between CYP21A2 and CYP21A1P promoters could be involved in the nonclassical phenotype. Therefore CYP21A2 promoter analysis should be included in genetic studies of 21OHD. |
---|---|
ISSN: | 0021-972X 1945-7197 |
DOI: | 10.1210/jc.2006-2163 |